Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection
- PMID: 8394145
- DOI: 10.1007/BF01788133
Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection
Abstract
A potent lupus anticoagulant (LA) was detected in four children, 1 week after the clinical onset of an adenovirus infection. The adenovirus infection was documented by direct virus detection in the stool of one patient and serologically in the others. None of the children had elevated titers of IgM- and only one of IgG-anticardiolipin antibodies (ACA). All patients had a marked reduction of prothrombin activity as well as antigen. Prothrombin-antibody complexes were demonstrated in the patients' plasma or mixtures of patient and normal plasma. Factor XII activity was moderately reduced in three of the patients. All coagulation abnormalities returned to normal within 4-12 weeks. Localized bleeding was observed in two cases, but there was no generalized bleeding tendency or evidence of thrombosis.
Similar articles
-
Association of lupus anticoagulant with transient antibodies to prothrombin in a patient with hypoprothrombinemia.Thromb Res. 1997 Apr 1;86(1):73-8. doi: 10.1016/s0049-3848(97)00047-9. Thromb Res. 1997. PMID: 9172289 No abstract available.
-
Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.Am J Hematol. 2002 Nov;71(3):200-7. doi: 10.1002/ajh.10194. Am J Hematol. 2002. PMID: 12410576 Review.
-
Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome.J Rheumatol. 2006 Oct;33(10):2088-90. Epub 2006 Aug 15. J Rheumatol. 2006. PMID: 16924686
-
Prozone Effect in the Diagnosis of Lupus Anticoagulant for the Lupus Anticoagulant-Hypoprothrombinemia Syndrome.Am J Clin Pathol. 2016 Aug;146(2):262-7. doi: 10.1093/ajcp/aqw106. Am J Clin Pathol. 2016. PMID: 27473743
-
Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome-A case series with review of literature.Lupus. 2021 Apr;30(4):641-648. doi: 10.1177/0961203321988934. Epub 2021 Jan 28. Lupus. 2021. PMID: 33509039 Review.
Cited by
-
Lupus anticoagulants in two children--bleeding due to nonphospholipid-dependent antiprothrombin antibodies.Eur J Pediatr. 2012 Sep;171(9):1383-7. doi: 10.1007/s00431-012-1737-1. Epub 2012 Apr 19. Eur J Pediatr. 2012. PMID: 22527568
-
Successful Treatment of Life-threatening Bleeding Caused by Acquired Factor X Deficiency Associated with Respiratory Infection.Intern Med. 2020 May 15;59(10):1303-1308. doi: 10.2169/internalmedicine.4142-19. Epub 2020 Feb 5. Intern Med. 2020. PMID: 32023586 Free PMC article.
-
Lupus anticoagulant hypoprothrombinemia syndrome - could it be a sequelae of COVID-19?Blood Res. 2023 Mar 31;58(1):77-79. doi: 10.5045/br.2023.2022200. Epub 2023 Feb 27. Blood Res. 2023. PMID: 36843376 Free PMC article. No abstract available.
-
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE).J Immunother Cancer. 2023 Apr;11(4):e006561. doi: 10.1136/jitc-2022-006561. J Immunother Cancer. 2023. PMID: 37094988 Free PMC article. Clinical Trial.
-
Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient.Int J Hematol. 2025 Jun 5. doi: 10.1007/s12185-025-04020-1. Online ahead of print. Int J Hematol. 2025. PMID: 40471516